Podcasts about geneticists

Christopher Mason, a geneticist and NASA investigator and author of The Next 500 Years: Engineering Life to Reach New Worlds, outlines a 500-year plan to enable human survival beyond Earth. Central to his vision is the deontogenic ethical framework, which asserts that humanity has a "genetic duty" to serve as guardians of life across the universe. To facilitate interstellar travel on generation ships, Mason proposes using advanced tools like CRISPR to edit human genomes and epigenomes to survive extreme environments. This includes adapting biological lessons from tardigrades for radiation resistance and bears for hibernation during long transit. He envisions "chloro-humans" capable of photosynthesis and humans who can synthesize their own essential vitamins. Beyond biological tweaks, Mason discusses ectogenesis (artificial uteruses) to manage human development during multi-generational journeys. While radical, Mason argues these modifications ensure "planetary liberty," allowing humans to inhabit worlds like Mars or Titan safely. (1)

Matt Walker, Geneticist and CEO of Kindred Companion Sciences Learn more about your ad choices. Visit megaphone.fm/adchoices

Why are only 10% of people left-handed? Geneticists, developmental biologists, neuroscientists, and evolutionary biologists have all sought explanations, resulting in an astronomical amount of research into the mystery of handedness. No one has put all the pieces together yet, but over the last few years, some major new clues have emerged. On this episode of The Quanta Podcast, host Hannah Waters speaks with writer Natalie Wolchover and traces these new clues to uncover the mystery of human handedness. This topic was covered in a recent story for Quanta Magazine. Each week on The Quanta Podcast, Quanta Magazine editor in chief Samir Patel and Senior Editor Hannah Waters speak with the people behind the award-winning publication to navigate through some of the most important and mind-expanding questions in science and math.

0:00 The friend he hasn't seen since sixth grade 5:16 Angelina Jolie, BRCA, and the 20% nobody tells women about 18:23 What a cancer cell actually is - and why tumors evolve 26:31 How cancer actually kills you, and what a seizure is 32:14 The last cigarette: why he can't take the test every week 46:27 The best medicine in the world, and who can't get to it 1:03:23 Telling a family there's nothing left Noam hadn't seen Kenan Onel since high school in Ardsley, where Onel graduated first in the class and Noam, by his own account, drifted somewhere well below. Fifty years later Onel runs genetics and genomics at Roswell Park - the only comprehensive cancer center in all of western New York - and Noam has one thing he wants to ask him about. He's afraid of cancer. His grandfather died of it. His father died of it. He's taken the Grail blood test, it came back clean, and he wants to know why he can't just take it every week. What follows is part reunion and part interrogation. Onel explains what a cancer cell actually is, why tumors evolve like finches in the Galapagos, and what is physically happening to someone during a seizure. He explains how cancer kills - the mechanism, organ by organ. And he tells Noam that the test he's counting on just failed its biggest trial in the UK, which sets off the real argument of the hour: whether a guideline written for a population means anything at all to the one person sitting in the chair. Then, near the end, Noam asks how you tell a family there's nothing left to offer. The answer is the best thing in the episode. Also: the 20% of women who are high-risk and have never been told, the doctor who warned Noam that Pellegrino was bad for his son's bones, a scan booked by 4pm the next afternoon, and one entire podcast without mentioning Israel. Dr. Kenan Onel is Chief of the Division of Genetics and Genomics and Director of the Center for Precision Oncology and Cancer Prevention at Roswell Park Comprehensive Cancer Center. Live from the Table is the official podcast of the world-famous Comedy Cellar.

0:00 The friend he hasn't seen since sixth grade 5:16 Angelina Jolie, BRCA, and the 20% nobody tells women about 18:23 What a cancer cell actually is - and why tumors evolve 26:31 How cancer actually kills you, and what a seizure is 32:14 The last cigarette: why he can't take the test every week 46:27 The best medicine in the world, and who can't get to it 1:03:23 Telling a family there's nothing left Noam hadn't seen Kenan Onel since high school in Ardsley, where Onel graduated first in the class and Noam, by his own account, drifted somewhere well below. Fifty years later Onel runs genetics and genomics at Roswell Park - the only comprehensive cancer center in all of western New York - and Noam has one thing he wants to ask him about. He's afraid of cancer. His grandfather died of it. His father died of it. He's taken the Grail blood test, it came back clean, and he wants to know why he can't just take it every week. What follows is part reunion and part interrogation. Onel explains what a cancer cell actually is, why tumors evolve like finches in the Galapagos, and what is physically happening to someone during a seizure. He explains how cancer kills - the mechanism, organ by organ. And he tells Noam that the test he's counting on just failed its biggest trial in the UK, which sets off the real argument of the hour: whether a guideline written for a population means anything at all to the one person sitting in the chair. Then, near the end, Noam asks how you tell a family there's nothing left to offer. The answer is the best thing in the episode. Also: the 20% of women who are high-risk and have never been told, the doctor who warned Noam that Pellegrino was bad for his son's bones, a scan booked by 4pm the next afternoon, and one entire podcast without mentioning Israel. Dr. Kenan Onel is Chief of the Division of Genetics and Genomics and Director of the Center for Precision Oncology and Cancer Prevention at Roswell Park Comprehensive Cancer Center. Live from the Table is the official podcast of the world-famous Comedy Cellar.

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Bret Bostwick from Breyer Capital about the rare path from genetics, clinical medicine and drug development into venture capital, and what that perspective reveals about the future of healthcare innovation.Bret shares how the release of the Human Genome Project first pulled him into genetics, and how clinical work with patients made the science deeply practical. As a medical geneticist, he saw families finally receive a diagnosis, but often without a treatment option. That experience led him towards programmable therapeutics, RNA-based medicines and the translational work required to move from biological insight into human trials.The conversation explores what makes a therapeutic company investable beyond the science alone. Bret explains why breakthroughs often fail not just because of technical risk, but because the right people, culture, operating experience and business model are not around the table. For him, one of the first questions is not simply “does the science work?” but “what problem is this company really solving, and is this the most elegant solution?”They also discuss where AI is overhyped and underestimated in medicine. Bret is sceptical of claims that AI can compress a 12-year clinical development journey into two years, because biology still requires time to evaluate safety and efficacy. But he sees enormous potential in agentic AI across the full healthcare and pharma stack, from discovery and preclinical design to manufacturing, commercialisation and patient finding.The key message is that the future of healthcare will belong to people and companies that can bridge disciplines: genetics, computation, medicine, product development and investment. The biggest opportunities may sit at the intersections, where scientific insight, platform thinking and practical translation come together.Topics CoveredMoving from genetics and clinical medicine into venture capitalLessons from RNA therapeutics and translational medicineWhy target genetics matters in drug developmentWhat investors look for beyond the scienceWhy the right team and culture are criticalPlatform companies vs single-asset thinkingWhere AI can and cannot compress drug developmentAgentic AI across pharma and healthcare workflowsFounder mistakes when pitching healthcare investorsEularis helps pharma and biotech leaders turn AI activity into board-defensible strategy and measurable commercial outcomes.If your organisation has plenty of AI in motion but very little that moves the commercial needle in a way the board can see, start with our 10-Day AI Diagnostic Sprint. It's a focused diagnostic that surfaces what's actually broken and what's blocking results, before you invest in a larger strategy effort.The Sprint diagnoses the problem. The AI Strategic Blueprint that follows is where we build the board-defensible strategy and plan.Details at eularis.com.AI platforms and tools solve specific problems. Strategy makes sure you're solving the right ones, in the right order. If you want help mapping priorities as you evaluate what to roll out next, send me a LinkedIn DM starting with ‘PRIORITIES' and two lines: what's already in flight, and the decision you're trying to make next.About the PodcastAI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results.This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more.Dr. Andree Bates LinkedIn | Facebook | X

In-ovo sexing has the potential to end the practice of male chick culling — and the technology seems to have finally caught up to the ambition. Greg hosted a panel on the topic at the Peak Conference, featuring Nancy Roulston, Senior Director of Corporate Policy and Animal Science at the ASPCA; Juliana Machado, Geneticist and Data Scientist at Hendrix Genetics; Casey Downey from Innovate Animal Ag; and Dr. Larry Sadler, Senior Vice President of the United Egg Producers.The panel digs into the current state of the technology, the real costs of adoption, and the coordination challenge of getting hatcheries, producers, retailers, and consumers all moving in the same direction.

It's common knowledge that many diseases and conditions have some kind of genetic link. But that wasn't always the case. In 1990, long before the Human Genome Project tied so many health issues to differences in genetics, researchers identified a gene called BRCA1. It was the first gene linked to a hereditary form of any common cancer. People with certain variants of BRCA1 stood a higher risk of developing breast and ovarian cancer than those without those mutations.   Geneticist Mary-Claire King and her lab were the first to identify that gene. She joined Host Flora Lichtman in September 2025 to talk about her background, her research, and her approach to science. Guest: Dr. Mary-Claire King is an American Cancer Society Professor in the departments of Genome Sciences and Medicine at the University of Washington in Seattle. Other episodes you may enjoy: A Nagasaki Survivor And Physician Recounts His Life's Work I Was Considered A Nobody Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-4-SCIFRI Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

When Vance Crowe learned he needed half his thyroid removed, it sparked a deep question: what does it mean when your body's clock gets disrupted? In this candid and wide-ranging conversation, Vance brings on geneticist and light researcher Kate Crosby — someone he talks to almost daily — to explore the science behind the body's hidden timekeepers.They dig into how the thyroid regulates hormones and why losing it might put you on "synthetic time," why vitamin D and magnesium are so tightly linked, how intense exercise can unlock forgotten memories, and the surprising ways your ancestral latitude shapes everything from your seasonal diet to your fertility. The conversation takes unexpected turns into sunlight exposure, skin hardening, the Protestant vs. Catholic divide mapped onto geography, and whether modern life has knocked our biological clocks permanently off course.This is the kind of conversation Vance wants his daughters to hear — honest, curious, and willing to follow ideas wherever they lead.Guest: Kate Crosby is a geneticist and researcher specializing in light biology and light recipes for plant growth and human health.Articulate.Ventures/IBCLegacyInterviews.com

Episode 365 Craig Venter, one of the world's most influential geneticists, has died aged 79. He leaves behind an incredible - and complicated - legacy. Venter is primarily known for playing a leading role in the sequencing of the human genome. Later he pioneered the field of synthetic biology, creating what was described as the first synthetic life form - a feat that was not without controversy. So what drove Venter? And why was he so compelled to promote the idea of science as a competitive race? We discuss his many achievements, including his work in marine biology - and explore the pioneering methods behind it all. Rowan Hooper and Penny Sarchet are joined by science writer Mike Marshall, and former New Scientist editor Roger Highfield. To read more about these stories, visit https://www.newscientist.com/ Image Credits: Marjorie McCarty, CC BY 2.5 https://creativecommons.org/licenses/by/2.5, via Wikimedia Commons Arienette22, CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0, via Wikimedia Commons The original uploader was Bruno Comby at English Wikipedia., CC BY-SA 1.0 https://creativecommons.org/licenses/by-sa/1.0, via Wikimedia Commons Learn more about your ad choices. Visit megaphone.fm/adchoices

Merlin G. Butler, MD, Medical Geneticist and Professor, Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, and one of the pioneers in Prader–Willi syndrome research, discusses the clinical features of this very rare disease and the critical importance of early identification. Prader–Willi syndrome was first reported in 1956, and deletions in chromosome 15 were first identified in the 1980s. Dr. Butler has been working on the genetics of Prader–Willi syndrome since that decade. Dr. Butler said that Prader–Willi syndrome was the first example of a disorder caused by “genetic imprinting,” in which it matters whether genes are contributed by the mother or the father. In 70% of the cases of this disorder, the father's contribution is missing from chromosome 15q13, and 25% of cases are the result of both copies of chromosome 15 being from the mother (referred to as “disomy”). Babies born with this genetic anomaly have severe hypotonia, and they have no interest in sucking or feeding. They often have decreased muscle mass and energy. “These infants look like they have a major problem at birth,” stated Dr. Butler. They need to be tube-fed. Once a genetic cause is suspected, Prader-Willi syndrome is quickly diagnosed; it is a very rare disease that also has very unique features. Pediatricians may see only one of these patients every 10 years. Therefore, according to Dr. Butler, “it is the parents who oftentimes make the diagnosis, through what they have seen on the Internet, prompting genetic testing.” Despite their problems with feeding in the neonatal period, infants with Prader–Willi syndrome will begin to gain an interest in feeding by around age 2 to 3 years. By age 6 years, they develop hyperphasia. “Once their appetite is turned on,” he said, “it is never off.” Uncontrolled, this results in obesity and life-threatening conditions, such as type 2 diabetes and stomach rupture.Early identification is key, and determining the genetic subtype is extremely important to building a multidisciplinary care team. There are seven different genetic subtypes, which can impact outcomes and management. Typically, the care team will include the medical geneticist and genetic counselors, endocrinologists (to manage the use of growth hormone and diabetes-related treatment), dietitians to manage and monitor caloric intake, mental health experts to address behavioral issues and the risk of self-injury, gastroenterologists, and potentially even sleep medicine professionals. The specialists comprising the care team will change over the patient's lifespan; occupational therapy and speech therapy may well be required as the patient ages. The treatment of hyperphagia associated with Prader–Willi syndrome, the number 1 issue, is a particularly active area of research. The idea is to avoid the onset of obesity, which can lead to most of the comorbidities and complications.  

Your doctor tells you that, should you wish to have a child, that child is likely also to carry the disease. But a new gene-editing technology could ensure that your baby is -- and remains -- healthy. Should you do it? Critics say the technology will exacerbate inequality and meddle in the most basic aspect of our humanity. Now, we debate: Should We Use Gene Editing to Make Better Babies? This ethical conundrum is at the crux of this week's debate, originally broadcast in February 2022. Arguing Yes: Dr. George Church, Geneticist & Founder, Personal Genome Project; Professor, Genetics, Wyss Institute and Harvard Medical School Amy Webb, Chief Executive Officer, Future Today Strategy Group; Professor, NYU Stern School of Business  Arguing No: Marcy Darnovsky, Executive Director, Emerita, Center for Genetics and Society  Françoise Baylis, Distinguished Research Professor, Emerita, Dalhousie University; President, Royal Society of Canada  Emmy award-winning journalist John Donvan moderates  Join the conversation on Substack - share your perspective on this episode and subscribe to our weekly newsletter for curated insights from our debaters, moderators, and staff.  Follow us on YouTube, Instagram, LinkedIn, X, Facebook, and TikTok to stay connected with our mission and ongoing debates.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Highly regarded Geneticist, Professor Ingrid Winship AO discusses the dynamic world of genomics and how a genetic test may impact you and your family.Drawing on her decades of experience Professor Winship provides practical information to help unpack the complexities of genetics that empowers people to make informed decisions.“What we do is about empowering people, trying to prevent predictable complications and keep healthy people healthy and genomics, genetic testing, genetic counselling, risk assessment and risk management are the cornerstones of that kind of preventative strategy.”Professor Winship discusses approaching genetics in a wholistic way and the importance of informed consent and the role genetic counsellors play in ensuring everyone understands, and is comfortable with the process.“The most important part of what we do is to be person focused – in genetics we extend this to the family.'

Kathryn Paige Harden (Original Sin On the Genetics of Vice, the Problem of Blame, and the Future of Forgiveness) is a psychologist, professor, and behavioral geneticist. Kathryn joins the Armchair Expert to discuss why psychology is not a solved problem, studying the essential question of why we do things we don't want to do, and how her religious upbringing was fundamentally at odds with her desire to study psychology. Kathryn and Dax talk about what living in a culture that embraces the concept of original sin means for our morality, genetic predictors of misdemeanor versus felony behavior, and our active human inclination to break stuff. Kathryn explains her belief that holding each other accountable is not a supernatural condition but a social one, why we can aim to be better in our institutions than in our worst moments, and the scientific fact that there's no evolution without diversity.Check Allstate first for a quote that could save you hundreds: https://www.allstate.com/Head to turbotax.com to find a store location near you and get matched with a TurboTax expert — with real-time updates in the iOS app.This episode is sponsored by AppleTV. Learn more at: https://tinyurl.com/mr2caw2cSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stress affects men and women differently. We sit down with Kiara Rodríguez-Acevedo, a Ph.D. candidate at the University of Pennsylvania to ask her how she is blending neuroscience and epigenetics to uncover how estrogen levels in the brain influence stress vulnerability and resilience.Support the showFor more information and sources for this episode, visit https://www.smartteapodcast.com.

When Insurance Gets Between Doctors and PatientsDr. Elizabeth Ames and Dr. Caleb Bupp are deeply committed to their patients. But like so many clinicians today, they're spending an extraordinary amount of time battling insurance companies instead of practicing medicine.Between prior authorizations, step therapy requirements, and outright coverage denials, physicians and their teams are buried in paperwork, often at the direct expense of patient care. Time that should be spent listening, diagnosing, and treating is instead consumed by forms, phone calls, and appeals.Boston Globe reporter Jonathan Saltzman raised the concern and Dr. Ames brought it to my attention. The reporter talks about, a new program rolled out by Blue Cross Blue Shield of Massachusetts. The insurer says the initiative is designed to control rising healthcare costs for its 3 million members, noting that costs have increased by 30 percent since 2021. But, the program specifically targets physicians who bill for the most expensive visits. The reason for the increased expense, which is discussed in our podcast, is because doctors are choosing to spend more time with rare disease patients who have complicated health issues. They need to spend more time with complex medical needs patients than say, someone with a sore throat.Drs. Ames and Bupp warn that this approach fundamentally misunderstands patient care, particularly for those with complex or rare conditions. “These patients don't need less time; they need more” says Dr. Ames. Physicians argue that policies like this risk rushed appointments, strained doctor/patient relationships, and poorer outcomes. Nowhere is this more concerning than in the rare disease community, where delays and denials can be devastating.Dr. Elizabeth Ames and Dr. Caleb Bupp talk about what this looks like in real life. As pediatric geneticists, they see firsthand how insurance barriers impact families already navigating diagnostic odysseys, uncertainty, and fear. Their work sits at the intersection of cutting-edge science and deeply human stories, and insurance interference often disrupts both. Dr. Ames, “Usually we get faxes saying, this has been denied and we start working on it. But the family gets a letter that the drug they need, the process is delayed by a “no”. We try and have good communication and say, “hey, we got this denial,” we're working on it. But I think it's deaths by a thousand cuts for the family. Families take the denial as, “I'm not worth of coverage, and that's really hard”. Dr. Bupp says they have had to hire genetic counselors, a job that didn't exist even 5 years ago, “We have a job description in our organization for it now because of the complexities that come with trying to unravel these insurance situations”.We should also note that Dr. Ames, Dr. Bupp, and I all serve on the Rare Disease Advisory Council (RDAC) in Michigan. “I think rare disease advocacy, there is power in numbers. One person can be a huge difference maker, but it's not one plus one equals two. It really exponentially grows, and I think with things like rare disease advisory councils, that gives you a better connection within your state, for state government and for advocacy. And I also think, or I hope, that it gives a place for an individual to plug in and that can then magnify and amplify. their voice so that they're not alone”. Many states have RDAC's, You can see if your state has an RDAC. For more on the Michigan RDACIn this article and in the podcast we are not speaking on behalf of the council, but it's important to understand why bodies like RDAC exist in the first place. Michigan is home to approximately one million people living with rare diseases, and the RDAC was created to ensure their voices, and experiences help shape policy. RDAC meetings are open to the public, and anyone in Michigan can participate and offer public comment. We hope you join our meetings via zoom (sometimes hybrid).This conversation isn't just about insurance policies. It's about time, trust, and whether our healthcare system truly serves patients, especially those with the most complex needs. Speak up, share your story. Advocate. Make a difference, Mold the future, for future generations.To look at the Everylife Diagnosis Odyssey https://everylifefoundation.org/delayed-diagnosis-study/ discussed in the podcast.  Everylife impact of diagnosis: https://everylifefoundation.org/burden-study/ Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/enRead us on Substack: https://substack.com/@lstb?utm_campaign=profile&utm_medium=profile-pageWatch our trailer of Embracing Egypt: https://youtu.be/RYjlB25Cr9Y

Episode 331 This week sees the broadcast on Channel 4 in the UK of a documentary called Hitler's DNA: Blueprint of a dictator. Geneticists have managed to find a DNA sample from Adolf Hitler and have sequenced it and verified it, and now we have his genome. The big question is what does this really tell us – what can we tell from someone's genome?  In this special episode of the podcast, Rowan Hooper is joined by two of the lead figures on the documentary. Turi King is a geneticist at the University of Bath and is best known for the identification of the remains of Richard III, and Alex Kay is a historian of Nazi Germany based at Potsdam University in Germany.  Rowan also discusses the documentary with New Scientist reporter Michael Le Page. To read more about these stories, visit https://www.newscientist.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Should you get genetic testing? Evolutionary geneticist Dr. Melissa Ilardo says: probably not. What you believe about your genes affects your health outcomes more than what your genes actually say. That's not philosophy—that's what the research shows. On this episode of Medical Disruptors, I sit down with Dr. Ilardo to discuss why genetic determinism is a trap and why your genes aren't writing your health story the way you've been told. We discuss why knowing your genetic risks might actually harm you through the nocebo effect, and how to distinguish between genetic mutations you must know like BRCA versus ones you shouldn't check. We explore what epigenetics actually means for your daily health decisions and why family history of diabetes, heart disease, or Alzheimer's is not your fate. The conversation reveals how lifestyle changes gene expression faster than you think, and why meditation and environment reshape your biology in measurable ways. Your genes load the gun, but your environment decides whether it fires. And you have far more control over that trigger than genetic testing suggests. Looking to schedule a consultation with Dr. E? Book here: drefratlamandre.com/consult Check us out on social media: drefratlamandre.com/instagram drefratlamandre.com/facebook drefratlamandre.com/tiktok #functionalmedicine #drefratlamandre #medicaldisruptor #NPwithaPHD #nursepractitioner #medicalgaslighting Chapters [00:00:00] Why resilience, not disease [00:06:45] Thailand spark: sea nomads [00:12:40] Betting the PhD [00:20:45] Bigger spleens, oxygen edge [00:28:50] Epigenetics in plain English Guest Links: IG: @superhumanscilab Website: https://www.superhumanlab.org Learn more about your ad choices. Visit megaphone.fm/adchoices

What genetic tests actually do—and what they don't—so you know when to use them (and when not to). Practical next steps. Chapters below. For step-by-step guides + live Q&A, join the community: https://familybuilding.net/building-your-family-community/ You'll learn: Screening vs diagnostic: what each actually tells you Carrier testing, NIPT, and embryo testing (PGT‑A/M): when it helps vs overkill Limits: false positives/negatives, VUS, and context (why “a result” ≠ a decision) Donor gametes: brief considerations for donor sperm/egg Questions to ask your clinic + first steps this week

If you could reduce medical risks for your future child, would you? A reproductive medicine doctor + geneticist explains what actually helps before pregnancy—so you know where to start today. You'll learn: what genetic screening covers (and doesn't), how to think about carrier testing and embryo testing, practical preconception steps to lower risk, and how to talk with your care team. Want live workshops and Q&A? Join the community: https://familybuilding.net/building-your-family-community/ Guest: Dr. Mili Thakur, MD/Geneticist • Host: Lisa Schuman, LCSW

It's common knowledge that many diseases and conditions have some kind of genetic link. But that wasn't always the case. In 1990, long before the Human Genome Project tied so many health issues to differences in genetics, researchers identified a gene called BRCA1. It was the first gene linked to a hereditary form of any common cancer. People with certain variants of BRCA1 stood a higher risk of developing breast and ovarian cancer than those without those mutations.  Geneticist Mary-Claire King and her lab were the first to identify that gene. She joins Host Flora Lichtman to talk about her background, her research, and her approach to science.Guest: Dr. Mary-Claire King is an American Cancer Society Professor in the departments of Genome Sciences and Medicine at the University of Washington in Seattle.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this episode of It Happened To Me, we share a story of love, loss, and advocacy in the rare disease community. We are joined by Jordan Kruse, whose son, Pruitt, was born with ornithine transcarbamylase (OTC) deficiency, and Dr. Susan Berry, a geneticist at M Health Fairview and professor at the University of Minnesota Medical School, who specializes in rare metabolic disorders like OTC deficiency and helped Pruitt.  OTC deficiency is a rare urea cycle disorder (UCD) that prevents the body from properly removing ammonia from the blood. This dangerous buildup can cause severe complications, and in Pruitt's case, tragically ended his life at only six months old.  Through her grief, Jordan founded The Brave Little One Foundation, honoring Pruitt's legacy by supporting families facing medical hardship and raising awareness about rare genetic conditions. Together, she and Dr. Berry shed light on: What OTC deficiency is and how it affects the body Why newborn screening doesn't always catch the condition The role of geneticists and medications in diagnosing and managing OTC deficiency Jordan's experience advocating for Pruitt's care in a complex medical system The importance of foundations and rare disease organizations in offering resources and hope What families and healthcare providers need to know about navigating rare disease diagnoses Resources: The Brave Little One Foundation National Urea Cycle Disorders Foundation (NUCDF)  The Rare Diseases Clinical Research Network (RDCRN Consortia) The Future of Personalized Medicine is Here: Baby KJ received a first-of-its-kind personalized gene editing therapy at CHOP to treat his urea cycle disorder Ornithine transcarbamylase deficiency explained by MedlinePlus    Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com. 

In this explainer episode, we've asked Dr Nour Elkhateeb, clinical fellow at Genomics England and clinical geneticist for the NHS, to explain the role of a clinical geneticist. The previous episode mentioned in the conversation is linked below. What is the diagnostic odyssey? You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you've got any questions, or have any other topics you'd like us to explain, let us know on podcast@genomicsengland.co.uk. You can download the transcript or read it below. Florence: What is a clinical geneticist? My name is Florence Cornish and I'm here with Nour Elkhateeb, clinical geneticist for the NHS and fellow at Genomics England, to find out more. So, Nour, before we dive into talking about clinical geneticists, could you explain what we mean by the term genetics? Nour: Hi Florence, so at its heart, genetics is the study of our genes and how they are passed down through families. Think of your genome as a huge, incredibly detailed instruction manual for building and running your body. This manual is written in a specific language, DNA, which is made up of millions of letters arranged in a specific order.  And here is the interesting part, we all have tiny differences in our genetic spelling, which is what makes each of us unique.  But sometimes a change in the instructions, a spelling mistake in a critical place, can affect health. Genetics is all about learning to read that manual, understand how changes in it can cause disease, how it's passed down through families and finding ways to help.   Florence: And so, what kind of thing does a geneticist actually do? Nour: Well, the term geneticist can cover a few different roles, which often work together. Crudely speaking, you can think of two main types, laboratory geneticists and clinical geneticists.   Laboratory geneticists are the incredible scientists who work behind the scenes. When we send a blood sample for genomic sequencing, they are the ones who use amazing technology to read the billions of letters in that person's instruction manual. The job is to find the one tiny spelling mistake among those billions of letters that might be causing a health problem.  Clinical geneticists like me are medical doctors specialised in the field of genetics, and we work face-to-face with patients and families in a hospital or a clinic setting. You can think of us as the bridge between the incredibly complex science of the genomics lab and the real-life health journey of the person in front of them. We diagnose, manage and provide support for individuals and families who are affected by or at risk of genetic conditions. And we translate that complex genetic information into meaningful information for the patient, the family and the other doctors as well.  Florence: So, let's talk a little bit more about clinical geneticists. What stage of someone's genomics journey are they likely to see you? What are some typical reasons they might get referred, for example?  Nour: That's a really good question. So, people actually can be seen by clinical geneticists at almost any stage of life, and for many different reasons. Let me give you some examples.  We see a lot of babies and children. A family may be referred to us if their baby is born with health problems that do not have a clear cause, or if a child is not developing as expected. And sometimes families may have been searching for answers for years, or what we call a diagnostic odyssey, but no one has been able to find a single unifying diagnosis to explain their challenges. And our job is to see if there is a genetic explanation that can connect all the dots.  Florence: You touched there on the diagnostic odyssey, and I know we don't have time to dive into that right now, but if listeners want to learn more about this, then they can check out our previous Genomics 101 podcast: What is the Diagnostic Odyssey? So, Nour, we know that you see children and families in their genomics journeys. Do you see adults as well?  Nour: Yes, indeed. We also see many adults who develop certain health conditions, such as cancer or certain types of heart disease, and their clinicians suspect they might be having an underlying inherited genetic cause, or it could be actually someone who is healthy themselves, but have a family history of a particular condition, and want to understand their own risk or the risk for their children and other family members. A classic example is in cancer genetics. A woman with breast cancer at a young age, or who has several family members who have also had it, she would be investigated to see if she carries a gene change that increases the risk of breast cancer and other cancers, and finding that actually would be critical for the treatment choices, and it has huge implications for her relatives.  Also, a major part of our work is in the prenatal setting, so we might see a couple during a pregnancy if the antenatal ultrasound scan, for example, shows that the baby has abnormalities. And the obstetrician might refer them to us to investigate if they have an underlying genetic reason for that. And this can help the couple and the medical team prepare for any challenges after birth and also make informed decisions about the pregnancy.   And clinical genetics is unique in that we don't see just individual patients, we often work with entire families, and if there is an inherited condition in the family, it's not unusual for several relatives across different generations to be seen by our team.  This family-wide approach helps us piece together the inheritance pattern and offer the right tests to the right people, and also ensure that everyone who might benefit from information or screening has the opportunity to access that.  Florence: So if someone has a suspected genetic condition, will they always come to you first?  Nour: Actually no, the way people come to us is changing. It used to be that you would always see clinical geneticists first, but now with genetic testing becoming more common, other clinicians like a cardiologist, a neurologist, or a paediatrician, might order a genetic test themselves.   But these tests can produce a huge amount of data, and the results are not always a simple yes or no. Sometimes the lab finds something called a variant of uncertain significance, which means a gene change that we are not certain whether it is the cause of health problems or not. And in these cases, a specialist will refer the patient to us to help put the uncertain result into the context of the patient's specific health problems, and family history, and to help also work out what it really means for them and their family.  Florence: So, you mentioned a couple of other healthcare professionals there, paediatricians and neurologists for example. Are there any other roles that you work closely with as a clinical geneticist?  Nour: Well, genetics is never a one-person job, and it's rather like a team sport, so we never work in isolation. We work in what we call a multidisciplinary team,  where clinical geneticists, genetic counsellors, genomic practitioners, scientists and other specialists, all bring our knowledge and expertise together. We also work directly with other specialists across the hospital and the NHS. Let's say if it's a genetic heart condition, a cardiologist would be a key part of this multidisciplinary team for the patient. And this 360-degree view ensures that we are giving the best possible holistic care.   Florence: And finally, before we wrap up, I'm sure lots of our listeners may have heard or even come across genetic counsellors. Could you explain how this role is different from a clinical geneticist?  Nour: So, our role as a clinical geneticist is distinct from that of a genetic counsellor, but we work side by side. Clinical geneticists, as the medical doctors on the team, we're often focused on the diagnosis, and we will perform a physical examination of the patient, looking for subtle clues. We will review their medical history, and piece together the whole medical puzzle. And based on that, we decide which genetic test is the most appropriate, and we'll have the best chance of finding an answer. A genetic counsellor is a healthcare professional with highly specialised training in both genetics and counselling. They are communication experts, they spend time helping families understand results, process the information, and think through what it means for them and their relatives. They are incredibly skilled at explaining complex genetic concepts in a way that is easy to understand, and also at providing support. They help families navigate the emotional impact of what can be life-changing news, and also discuss the implications for the wider family. And genetic counsellors are not only there after the diagnosis is made, they can also play an active role in the diagnostic process.  So in many situations, they are the ones taking the detailed family history, recognising patterns that suggest a genetic condition, and arrange the most appropriate genetic tests. They work closely with laboratory scientists and clinical geneticists to interpret the results and guide the next steps for the patient.  And a family will often see both of us as our roles complement each other.  Florence: So, we'll finish there. Thank you so much, Nour, for sharing what you do as a clinical geneticist.   If you'd like to hear more explainer episodes like this, you can find them on our website at www.genomicsengland.co.uk, or wherever you get your podcasts. Thank you for listening. 

In this episode of The Dairy Podcast Show, Dr. Hinayah Rojas, from Purdue University, shares valuable insights into the rapidly evolving field of genomics in dairy cattle. Dr. Rojas breaks down the challenges and opportunities presented by longitudinal traits like milk production, discussing how genomic tools are helping to boost sustainability across the industry. Additionally, Dr. Rojas offers advice on balancing motherhood with a demanding professional life. Listen now on all major platforms!"The lactation curve is complex, but genomics allows us to select animals not only for higher milk production but also for better lactation persistence."Meet the guest: Dr. Hinayah Rojas de Oliveira is an Assistant Professor of Genomics and Animal Breeding at Purdue University. She holds a PhD in Animal Sciences, focusing on Genetics and Animal Breeding, from the Federal University of Viçosa in Brazil. Dr. Rojas has completed postdoctoral work at the University of Guelph and Purdue University and previously worked as a Geneticist at Lactanet Canada. Her research aims to develop statistical models that maximize genetic progress while preserving diversity in livestock species.Liked this one? Don't stop now — Here's what we think you'll love!What you'll learn:(00:00) Highlight(01:30) Introduction(02:35) Dr. Rojas's journey(08:52) Genomics in dairy cattle(11:55) Longitudinal traits(14:30) Genomic & efficiency(17:11) Sustainability & genomics(28:35) Final questionsThe Dairy Podcast Show is trusted and supported by innovative companies like:* Adisseo* Lallemand* Priority IAC* Evonik- ICC- AHV- Protekta- Natural Biologics- SmaXtec- Berg + Schmidt- dsm-firmenich

Why are cats orange? Meet Dr. Leslie Lyons, one of the world's foremost experts in feline genetics. In this episode of Purr Podcast, we are demystifying orange cats! Dr. Lyons discusses new studies that revealed a never-before-seen genetic pathway for color pigmentation linked to orange cats.

Joining us now to unpack this cutting-edge science which states that babies being made with three people’s DNA, are born free of hereditary diseases is Dr. Monique Zaahl, a South African geneticist with expertise in rare diseases and genomic innovation – what could this mean for South Africa? Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

In 1980, influential paleontologist and evolutionary biologist Stephen Jay Gould wrote that “we can know that evolution has happened by the imperfections and oddities that life shows.” But is that true? And what if we take a closer look at those assumed evolutionary oddities and see instead evidence of engineered elegance? On this ID The Future, host Andrew McDiarmid welcomes retired geneticist Dr. Wolf-Ekkehard Lönnig to the podcast to discuss his new paper reviewing the debate over the panda's thumb. Giant pandas have an elongated wrist bone, the radial sesamoid, that allows them to handle and eat bamboo with great dexterity. Some claim it's an imperfectly and inefficiently formed structure that is clear evidence of evolutionary processes at work. Others Read More › Source

Professor Gareth Baynam is a globally recognised clinical geneticist, researcher, and advocate for rare diseases. He is the Director of the Rare Care Centre at Perth Children's Hospital and the Head of the Western Australian Register of Developmental Anomalies. With a career dedicated to improving the diagnosis, management, and care of individuals with rare and genetic conditions, he has been at the forefront of integrating cutting-edge technologies such as genomics, artificial intelligence, and precision medicine into healthcare. Professor Baynam is also a leader in Indigenous health initiatives, championing equitable access to rare disease diagnostics and treatment. Through his work with organizations such as the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease and the European Rare Diseases Research Alliance (ERDERA),  he continues to drive global collaborations and innovations that aim to transform rare disease care.

In the ever-evolving world of poultry breeding, understanding genetics is a game-changer for breeders looking to improve their bloodlines and strains. In this episode of Bred to Perfection hosted by Kenny and Nancy Troiano, they shine a spotlight on the fascinating world of poultry genetics. Geneticist and breeder Brian Reeder shares invaluable insights on various aspects of genetics, epigenetics, and their impact on poultry breeding. From enhancing disease resistance to selecting for desirable behaviors, this conversation provides crucial knowledge for breeders seeking to improve their bloodlines and strains. Make sure to follow and watch our future shows. We plan to dive deep into the world of breeding and genetics, nutrition and health management, and provide essential tips, so you too can create high quality strains.  Whether you're breeding domestic chickens, gamefowl, or various types of livestock, this show is for you.  Join us on Bred to Perfection Live, Friday's at 6pm PST or 9pm EST on YouTube, as we discuss the benefits of creating your own strain. See ya there! Kenny Troiano Founder of "The Breeders Academy" We specialize in breeding, and breeding related topics. This includes proper selection practices and the use of proven breeding programs. It is our mission to provide our followers and members a greater understanding of poultry breeding, poultry genetics, poultry health care and disease prevention, and how to improve the production and performance ability of your fowl.  If you are interested in creating a strain, or improving your established strain, you are in the right place.  We also want to encourage you to join us at the Breeders Academy, where we will not only help you increase your knowledge of breeding and advance your skills as a breeder, but improve the quality and performance of your fowl. If you would like to learn more, go to: https://www.breedersacademy.com In this episode of Bred to Perfection, the host Kenny Troiano and Brian Reeder discusses the intricacies of poultry breeding, focusing on genetics, epigenetics, disease resistance, and effective selection practices. Kenny and Brian emphasize the importance of selecting for the 'complete package' rather than singular traits, and share insights on how environmental factors and nutrition impact genetic expression. The episode also touches on the role of various genetic factors, the importance of disease resistance through natural selection, and tips for adapting birds to different diets. Additionally, resources, such as Brian Reeder's books on poultry genetics are recommended for breeders interested in improving their fowl. #breedinggamefowl #breedingchickens #gamefowlbreeding #chickenbreeding, #gamefowlnation, #selectivebreeding, #poultryhealth #backyardbreeders #breedersacademy #bredtoperfection #gamefowl #Epigenetics #dogbreeding #gamefowlnation #poultryhealth #backyardbreeders #bredtoperfection #PoultryBreeding #KennyTroiano #BackyardChickens #ChickenBreeding #SelectiveBreeding #Linebreeding #PoultryGenetics #HeritageBreeds #ChickenStrains #LivestockBreeding #SustainableFarming #HomesteadingLife #PurebredPoultry #FlockManagement #PoultryPodcast

The US Supreme Court heard oral arguments Friday on South Carolina's attempt to stop Medicaid payments to Planned Parenthood. Geneticists are promoting frightening plans to create babies to specifications. And gambling on sports continues to grow, leaving problems in its wake. Recommendations NYT: This baby was carefully selected as an embryo. ADF: Supreme Court to Hear Case About States' Funding of Abortion Facilities Segment 1 - States Try to Stop Medicaid Payments for Abortion FOX: Who is Stephanie Turner? Women's fencer who knelt to protest trans opponent and ignited global awareness ADF: Planned Parenthood Does Not Deserve Your Tax Dollars Segment 2 - Designer Babies NYT: This baby was carefully selected as an embryo. CBS: "What kind of society do you want to live in?": Inside the country where Down syndrome is disappearing First Things: Who Owns the Embryos? CNN: Gosnell horror fuels fight for abortion laws Breakpoint: Inventors of CRISPR Win Nobel Prize, but Should We “Rewrite the Code of Life?” Segment 3 - The Sports Gambling Crisis WORLD: Gambling scandals hover over college and pro basketball __________ Restore hope and make communities safer by partnering with Prison Fellowship at prisonfellowship.org/colsoncenter. Register for the next Lighthouse Voices: The Christian's Guide to this 'Civilizational Moment' at colsoncenter.org/lighthouse. 

Scientists have genetically engineered mice with some key characteristics of an extinct animal that was far larger — the woolly mammoth. Colossal Biosciences, a Dallas company, is trying to revive the Wooly Mammoth and, in the process, created a cute, cuddly, hairy, wooly rodent. Yes, it is fascinating, but it is also concerning whether or not we resurrect the Mammoth ala Jurassic Park. Geneticists perform this unbridled mad science because it is possible, but they never think about why they shouldn't and what the long-term ramifications are of playing God. Clyde Lewis talks about GENESIS OF THE GOD WEB tonight on Ground Zero (7-10 pm, pacific time on groundzeroplus.com).

Highlights:1) How the Giant Ant People saved the Hopi Indians during global cataclysms?2) What real beings live subterraneous, inside the Earth, that we're unaware of?3) Time Units: Temporal Dimensions & Shifting Timelines?4) Genetic seeding and races who are master geneticists?My guest Tim is a Tactical Advisor who has experience working in the covert European governance sector, as well as working with extraterrestrial contact and advanced technologies. Tim has published various articles, podcasts, and Gaia appearances (Cosmic Disclosure, Open Minds, and Truth Hunter) covering extraterrestrial life, advanced technologies, and cosmic phenomena. Tim's insights are informed by his extensive network and interactions with ten different extraterrestrial species, including more than 100 meetings with the Greys. He has experience within undisclosed projects and Cosmic Disclosure. To learn more, you can find him at: ⁠allshifthappilynow.com⁠Want to know what your galactic ancestry is? Unlock your cosmic potential with a FREE Starseed Video and Report!

Episode 193 is here...the boys discuss, Vargo's bday, pops, Josh's trip to the ER, Landman, Bad Monkey, Daredevil, Evelynn and the Geneticist, WVU football schedule, Neal Brown, Josh's personal protest, Iowa State day of glory, losing streak, Cinci, National Championship game, can we get to 19, wvu fantasy lineup, and becoming your dad.

After 15 months of devastating conflict, a ceasefire agreement has been reached between Israel and Hamas, and three female hostages – Romi Gonen, Emily Damari, and Doron Steinbrecher - have been released and are now back in Israel. This release is the first of several expected over the next six weeks, with a total of 33 hostages to be returned. Ninety Palestinian prisoners were released overnight in exchange for the hostages, the Israeli prison service has said - most of them women and teenage boys. The UN estimates that 1.9 million people in Gaza have been internally displaced since the start of the most recent conflict, some 90% of the population. The humanitarian situation remains critical, with widespread destruction and significant damage to infrastructure including hosptials and severe shortages of food, fuel, medicine, and shelter. Datshiane Navanayagam speaks to BBC Chief Correspondent Lyce Doucet. We also hear from Ghada Al-Kourd in Deir al-Balah in the centre of the Gaza strip, and Sharone Lifschitz, whose parents were taken hostage by Hamas in October 2023.Geneticists from Trinity College Dublin and archaeologists from Bournemouth University have found evidence of female political and social empowerment during Britain's Iron Age. DNA sampled from a burial site in Dorset shows that two-thirds of the women were closely related, suggesting that women lived in the same communities and passed on their land and wealth to their daughters, while unrelated men tended to join the community from elsewhere. This type of social structure, known as “matrilocality” is the first documented instance in European pre-history and challenges the assumption that most societies were patrilocal. Dr Lara Cassidy, an Assistant Professor of Genetics at Trinity College Dublin who led the research, discusses the findings. President-elect Donald Trump will be inaugurated today in Washington D.C. It is of course his second term, having previously served as the 45th US president, he will now also become the 47th. So what will a second Trump presidency mean for women, both in the US and around the world? Datshiane is joined by Jennifer Ewing from Republicans Overseas and the BBC's Holly Honderich to discuss.Elise Downing is known for running 5,000 miles self-supported around the British coast over the course of 10 months. She was not only the youngest person, but also the only female to have completed the challenge. Along the way she saw Britain at its wild and wonderful best. She has now written Walk Britain, packed with inspiring car-free ideas on how to get out and explore stunning locations – from the Cornish coast to the Yorkshire Dales and the Isle of Arran.  She joins Datshiane to talk about some of the 90 different routes across that can be completed on foot, all accessible by public transport.Presented by Datshiane Navanayagam Producer: Louise Corley

To access the full bonus episode, sign up for our Patreon.Our guest today is Manon de Visser, a biologist from the Netherlands — who first reached out to us to provide more information about ‘The Man With 1000 Kids' — but our conversation went so much further, including sneaky fuckers and childfree animals. Manon's expertise varies from studying animals in zoos, museums, and universities, and she also runs her own science communication company, 'Wild DNA' (Which, BTW, You can find her on Instagram with her handle @wild_DNA). Multitasking is clearly in her DNA, as she is about to complete her PhD in evolutionary genetics! She happily lives in her cozy home in the Netherlands with her husband, two cats, and an elderly rabbit. Become a supporter of this podcast: https://www.spreaker.com/podcast/dinky--5953015/support.

Send us a textIn this compelling episode, we dive into a powerful conversation with Dr. Jenn Caldwell, Assistant Professor at the Pennington Biomedical Research Center and Director of the Public Health Genomics and Health Equity Laboratory at LSU. Dr. Caldwell unpacks her groundbreaking research on health equity, genetic testing, and community-driven solutions to tackle chronic illnesses disproportionately affecting marginalized communities. From exploring the ancestral roots of African Americans through the Gullah Geechee community to the transformative "Lincoln Gains Project," Dr. Caldwell sheds light on the intersection of genetics, lifestyle, and public health.We discuss the pressing challenges of systemic racism, the cultural significance of HBCUs, and practical tips for achieving healthier lifestyles despite socioeconomic barriers. Whether you're curious about the role of epigenetics, the importance of representation in research, or actionable ways to improve wellness in underserved communities, this episode offers an engaging blend of science, culture, and storytelling.This is a must-watch for socially conscious audiences, culturally engaged Millennials and Gen Xers, educators, and professionals who seek authentic narratives that inspire change. Join us for a thought-provoking journey into how genetics and culture shape our lives and communities. Don't forget to like, comment, and subscribe for more insightful discussions! #healthequity  #genetics  #BlackExcellence #hbcu  #wellnessjourney  #socialjustice  #notallhood-----------------------------------------------------------------------------------------------------Not All Hood (NAH) podcast takes a look at the lived experiences and identities of Black people in America. Infused with pop culture, music, and headlining news, the show addresses the evolution, exhilaration, and triumphs of being rooted in a myriad of versions of Black America. Hosted by Malcolm-Jamal Warner, Candace O.Kelley, and WeusiBaraka Executive Produced by Layne Fontes Produced by Kelly Brett Associate Producer Troy W. Harris, Jr.

Rather amazingly, there hasn't been much research into the causes and potential cures for the nausea that around 70% of people experience during pregnancy. Until now.Thankfully, Dr Marlena Fejzo is dedicating her life's work to finding ways to alleviate the full spectrum of mild cases of "morning sickness" to severe nausea to, on the extreme end, hyperemesis. She herself experienced hyperemesis. She knows firsthand the debilitating effects of the disease. Already she has clearly identified one gene (GDF15) linked to the cause and she is working on finding more.Listen to the full episode to learn what Dr Fejzo recommends for alleviating symptoms of morning sickness and treating true hyperemesis. There are ways to find some relief now, even ahead of the groundbreaking new therapies that are on the horizon.Full show notes: fourthtrimesterpodcast.com (all links below can also be found here)Connect with Dr Marlena Fejzo USC Profile & Contact | USC Marlena Fejzo Research FundLearn more Time Women Of The Year 2024 | Harmonia Healthcare Clinics for Nausea & Hyperemesis Treatment | HER Foundation RESOURCES | 23andMeConnect with Fourth Trimester Facebook | Instagram | About & Contact

Send us a textA multifaceted understanding of wisdom is essential for a functioning society.  Only with this broad understanding can we humbly dialogue with those who disagree with us and piece by piece build a culture of conversation. In this episode, I sit down with geneticist and physician Dr. Francis Collins to discuss his latest book, Road to Wisdom. Dr. Collins argues that we must return to the four core sources of judgment and clear thinking: truth, science, faith, and trust.A Quick Note:Aiming for the Moon has a diverse audience. I strongly believe that developing your perspective comes from speaking with people who you both agree with and disagree with. Iron sharpens iron. That's why this podcast is a platform that hosts interesting and successful people from a variety of worldviews. Gen. Z has the opportunity to trailblaze a culture of conversation. So, let's go.Topic:Four Anchors of Knowledge: Truth, Science, Faith, and TrustCynicism and Nihilism in Public Discourse The Importance of Humility in Dialogue"How has being attacked by those 'on your side?' changed how you communicate?"Harmonizing Faith and ScienceIron sharpens Iron: How going outside your bubble helps expand your perspectiveNavigating Polarized Issues in a Multicultural SocietyPractical Steps: So, how should we then live?"What books have had an impact on you?""What advice do you have for teenagers?"Bio:Dr. Francis S. Collins is a physician and geneticist. His groundbreaking work has led to the discovery of the cause of cystic fibrosis, among other diseases.  In 1993 he was appointed director of the international Human Genome Project, which successfully sequenced all 3 billion letters of our DNA. He went on to serve three Presidents as the Director of the National Institutes of Health.Resources mentioned:Road to WisdomTaylor's Substack: The Dangers of Abstracting Individuals in a Divided SocietyEp. 80. The Perception of Political Polarization and How to Fix It: Dr. Chris BailThe Anxious Generation by Jonathan HaidtBooks of impact:BibleMere Christianity by C.S. LewisThe Constitution of Knowledge by Jonathan RauchSocials -Lessons from Interesting People substack: https://taylorbledsoe.substack.com/Website: https://www.aimingforthemoon.com/Instagram: https://www.instagram.com/aiming4moon/Twitter: https://twitter.com/Aiming4MoonFacebook: https://www.facebook.com/aimi

Justin Esquivel is CEO & Geneticist, Green Luster Phenos™ and has been an influencer and leader in the cannabis industry for 15 years. Esquivel was the head grower and geneticist of an indoor commercial-scale cultivation operation back in 2012.  Justin has consulted with over 100 cannabis facilities, 72 of which operate commercial canopies.  Esquivel provides home growers with pest and bacteria-resistant genetics in seed and breeders' cut form on a global scale!  He brings standard operating procedures to a gold standard.  His one-of-a-kind approach to plasticity breeding has sparked tons of interest across the globe.  Esquivel also specializes in Cannabis Tissue Culture & Selective Homozygous Breeding, enabling his company to bring exotic tailored offspring to growers globally!During our conversation, we discuss:  Justin's background in traditional ag and how that applies to cannabis  How he uses tissue culture to store genetics and eliminate pathogens  The process for creating stable cannabis varieties How purposely introducing pests into the breeding room helps select for resistance traits  The application of analytical tools, such as PCR, HPLC, and marker-assisted breeding  Thanks to this episode's Sponsor: Rare Earth Genomics.  Rare Earth Genomics is a dynamic partnership formed with Texas A&M AgriLife, one of the world's leading research institutions, to accelerate hemp research and create tools for farmers. Their mission is to increase the likelihood of a successful harvest for farmers through genetic analysis and rigorous environmental testing of vigorous cultivars.  Learn more at rareearthgenomics.com  Additional Resources:  greenlusterphenos.com Review the Podcast CannMed Archive

PREVIEW: MEDICINE: Conversation with geneticist Christopher Mason, author of "The Next 500 Years," explains the compiling of a database on the effects of space travel on humans. More later. 1930

Against the odds, a tiny Icelandic town speaks of a local Black ancestor. Geneticists and historians combine forces to uncover the man's eventful life.

Against the odds, a tiny Icelandic town speaks of a local Black ancestor. Geneticists and historians combine forces to uncover the man's eventful life.

Join us for a riveting exploration into the microscopic world of germs and vaccines in this special podcast episode featuring PhD Geneticist, Ian Copeland. Ian delves deep into the fascinating realm of germs, discussing their mechanisms of infection, evolution, and the pivotal role they play in shaping human health and history. With his expertise, Ian unpacks the science behind vaccines, shedding light on how they work to protect us from harmful pathogens. From historical epidemics to cutting-edge research, this episode offers insights into the battle against infectious diseases. Plus, Donnie joins the show to tell us the story of his heroic plane incident and how he saved the lives of many and we get into Tennessee basketball, the NBA all star game, Enhanced games and PEDs and much more. Enjoy! (00:02:47) Donnie tells his story about saving a plane (00:26:41) Dude of the week (00:37:25) Tennessee Minute (00:44:50) Bitcoin mining (00:48:30) Enhanced games (01:04:57) Germs and viruses (01:24:23) PHD Geneticist - Ian CopelandYou can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/macrodosing

Giants in their fields of music and science are merging their knowledge to propel advancements in body and mind. A recent international gathering of researchers, therapists and artists took stock of what is known and what is yet to be discovered. Jeffrey Brown reports for our ongoing arts and health coverage on CANVAS. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Dr. Mike Brasher recently joined the crew from Campus Waterfowl for an opportunity to reconnect with his roots, as he shared a soggy morning in the cypress swamp with current and former students of his alma mater, Mississippi State University. This episode, which originally aired on Campus Waterfowl, recaps an exciting ring-neck hunt and shines a spotlight on the passion this group has for waterfowl and wetland conservation through their work on the Mississippi State chapter of Ducks Unlimited. Joining on the podcast were Derek Christians of Campus Waterfowl and Drew Brown and Hunter Yelverton from Mississippi State. The group also discussed duckDNA, the exciting project that is connecting duck hunters with scientists to inform some of today's most ground-breaking research. www.ducks.org/DUPodcastwww.campuswaterfowl.com

 The Age of Prediction is such a fascinating book! After reading it, I really do think the job people should be preparing for is “data analyst” or “predictor”, because that's going to be used in every single industry, more than prompt engineers or AI coders - because AI is going to write its own code. Being able to understand what data to look at and why and how to make use of it, whether it's the medical industry or sports or stocks or insurance or art, this is going to be such a valuable skill to have, and it's a just beginning field. The creativity there is going to be amazing.The Age of Prediction: Algorithms, AI, and the Shifting Shadows of Risk by Christopher Mason and Igor Tulchinsky is like a guidebook to what's happened, what's going to be happening, and all the different ways people use will prediction technology.Igor has a $7 billion hedge fund, which analyzes millions of pieces of data around the world to predict stocks, whether something will happen tomorrow, or an hour from now, or 10 seconds from now.Christopher Mason is geneticist and computational biologist who has been a Principal Investigator and Co-investigator of many NASA missions and projects. I wanted to know: What is the state of this industry? How much can we really predict? How can we get better at it? What are the limitations? How close are we to manipulating DNA for disease gene removal? Can single-gene editing be done within a living human? We talk about all of that, and then just have a fun time while I pitched different ideas. Enjoy our interview with Igor and Chris, authors of The Age of Prediction.-----------What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!------------Visit Notepd.com to read our idea lists & sign up to create your own!My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.I write about all my podcasts! Check out the full post and learn what I learned at jamesaltucher.com/podcast.------------Thank you so much for listening! If you like this episode, please rate, review, and subscribe  to “The James Altucher Show” wherever you get your podcasts: Apple PodcastsStitcheriHeart RadioSpotifyFollow me on Social Media:YouTubeTwitterFacebook